• R-Biopharm AG
  • Contact
  • Media
  • Online Seminars
  • Events
Languages
  • Nederlands
  • Italiano
  • Français
  • Deutsch
  • Español
  • English
Subscribe
  • Start
  • Diagnostics
    • Allergology
    • Autoimmunity
    • Bacteriology
    • Gastroenterology
    • Human genetics
    • Mycology
    • Parasitology
    • Tuberculosis
    • Virology
    • Syndromic Testing
  • Indication
    • Allergies
    • Hospital acquired infections & drug resistance
    • Gastrointestinal infections
    • Dermatological Infections
    • Respiratory infections
    • STI & UTI
    • Genetic predisposition
    • Therapeutic drug monitoring
    • Vector-borne infections
  • Technologies
    • Array
    • Blots
    • ELISA
    • PCR
    • Rapid tests
    • Quality Assessment Products
    • MT-PCR
  • Systems
  • Product Finder
  • News
  • Shop
A Division of the R-Biopharm Group
  • Start
  • Diagnostics
    • Allergology
    • Autoimmunity
    • Bacteriology
    • Gastroenterology
    • Human genetics
    • Mycology
    • Parasitology
    • Tuberculosis
    • Virology
    • Syndromic Testing
  • Indication
    • Allergies
    • Hospital acquired infections & drug resistance
    • Gastrointestinal infections
    • Dermatological Infections
    • Respiratory infections
    • STI & UTI
    • Genetic predisposition
    • Therapeutic drug monitoring
    • Vector-borne infections
  • Technologies
    • Array
    • Blots
    • ELISA
    • PCR
    • Rapid tests
    • Quality Assessment Products
    • MT-PCR
  • Systems
  • Product Finder
  • News
  • Shop

Archives

Tag Archives for: "TDM"
Home » TDM
New ELISA test for the monitoring of the Ustekinumab drug level

New ELISA test for the monitoring of the Ustekinumab drug level

Studies have shown that some patients do not respond or respond inadequately to therapies for chronic intestinal diseases like for example Inflammatory Bowel Disease. The biologic drug [...]

READ MORE
Better therapy, lower costs: Optimizing the treatment of IBD (en)

Better therapy, lower costs: Optimizing the treatment of IBD (en)

So-called TNFα blockers are commonly used in the treatment of inflammatory bowel diseases (IBD) such as Crohn’s disease and ulcerative colitis. Therapeutic drug monitoring improves the effect of [...]

READ MORE
TNFalpha blocker and drug monitoring (en)

TNFalpha blocker and drug monitoring (en)

TNFalpha blocker are biologic agents, which are used for the treatment of inflammatory diseases such as Ulcerative Colitis, Crohns disease and Rheumatoid Arthritis. Infliximab as well as [...]

READ MORE

Clinical Diagnostics

A division of R-Biopharm AG
Subscribe to our newsletter
Company information
  • R-Biopharm AG
  • An der Neuen Bergstraße 17
    64297 Darmstadt, Germany
  • +49 (0) 61 51 - 81 02-0
  • +49 (0) 61 51 - 81 02-40
  • info@r-biopharm.de
  • www.r-biopharm.com
Copyright All Rights Reserved ©
  • Imprint
  • Privacy policy
  • GTCs
  • GTCs (Purchase)

Start typing and press Enter to search

TWEST SIS